Cargando…

The transcriptional modulator BCL6 as a molecular target for breast cancer therapy

Inappropriate expression or activation of transcription factors can drive patterns of gene expression leading to the malignant behavior of breast cancer cells. We have found that the transcriptional repressor BCL6 is highly expressed in breast cancer cell lines, and its locus is amplified in about h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walker, Sarah R., Liu, Suhu, Xiang, Michael, Nicolais, Maria, Hatzi, Katerina, Giannopoulou, Eugenia, Elemento, Olivier, Cerchietti, Leandro, Melnick, Ari, Frank, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175367/ https://www.ncbi.nlm.nih.gov/pubmed/24662818 http://dx.doi.org/10.1038/onc.2014.61

Ejemplares similares

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
por: Dupont, Thibault, et al.
Publicado: (2015)

Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated through distinct biochemical mechanisms
por: Huang, Chuanxin, et al.
Publicado: (2013)

A purine scaffold Hsp90 inhibitor destabilizes Bcl6 and has specific anti-tumor activity in Bcl6 dependent B-cell lymphomas
por: Cerchietti, Leandro C, et al.
Publicado: (2009)

BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms
por: Hatzi, Katerina, et al.
Publicado: (2015)

BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
por: Hurtz, Christian, et al.
Publicado: (2011)

An integrated ChIP-seq analysis platform with customizable workflows
por: Giannopoulou, Eugenia G, et al.
Publicado: (2011)

Inferring chromatin-bound protein complexes from genome-wide binding assays
por: Giannopoulou, Eugenia G., et al.
Publicado: (2013)

Histone Demethylase LSD1 is required for Germinal Center formation and BCL6-driven lymphomagenesis
por: Hatzi, Katerina, et al.
Publicado: (2018)

CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3
por: Egusquiaguirre, Susana P., et al.
Publicado: (2019)

BCL6 is critical for the development of a diverse primary B cell repertoire
por: Duy, Cihangir, et al.
Publicado: (2010)

Use of RNA sequencing to evaluate rheumatic disease patients
por: Giannopoulou, Eugenia G, et al.
Publicado: (2015)

Aberration in DNA Methylation in B-Cell Lymphomas Has a Complex Origin and Increases with Disease Severity
por: De, Subhajyoti, et al.
Publicado: (2013)

Epigenomic evolution in diffuse large B-cell lymphomas
por: Pan, Heng, et al.
Publicado: (2015)

BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL
por: Xia, Min, et al.
Publicado: (2022)

BCL6 enables Ph(+) acute lymphoblastic leukemia cells to survive BCR-ABL1 kinase inhibition
por: Duy, Cihangir, et al.
Publicado: (2011)

Genome-Wide Detection of Genes Targeted by Non-Ig Somatic Hypermutation in Lymphoma
por: Jiang, Yanwen, et al.
Publicado: (2012)

Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma
por: Ricker, Edd, et al.
Publicado: (2020)

Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma
por: Verma, Akanksha, et al.
Publicado: (2015)

Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia
por: Hurtz, Christian, et al.
Publicado: (2019)

The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells()
por: Egusquiaguirre, Susana P., et al.
Publicado: (2018)

THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
por: Cayrol, Florencia, et al.
Publicado: (2017)

Epigenetic profiles signify cell fate plasticity in unipotent spermatogonial stem and progenitor cells
por: Liu, Ying, et al.
Publicado: (2016)

Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas
por: Cerchietti, Leandro, et al.
Publicado: (2011)

The epigenetic regulator CTCF modulates BCL6 in lymphoma
por: Batlle-López, Ana, et al.
Publicado: (2015)

Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
por: Cayrol, Florencia, et al.
Publicado: (2017)

DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activation
por: Lai, Anne Y., et al.
Publicado: (2013)

Role of the Transcriptional Repressor BCL6 in Allergic Response and Inflammation
por: Arima, Masafumi, et al.
Publicado: (2008)

Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023)

Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma
por: Napoli, Sara, et al.
Publicado: (2021)

The Ansamycin Antibiotic, Rifamycin SV, Inhibits BCL6 Transcriptional Repression and Forms a Complex with the BCL6-BTB/POZ Domain
por: Evans, Sian E., et al.
Publicado: (2014)

NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells
por: Gao, Min, et al.
Publicado: (2020)

BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy
por: Slone, William L., et al.
Publicado: (2016)

The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy
por: Fabre, Marie-Sophie, et al.
Publicado: (2020)

High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
por: Tsai, Cheng-Chih, et al.
Publicado: (2021)

Targeting BCL6 and STAT3 in triple negative breast cancer: the one-two punch?
por: Walker, Sarah R., et al.
Publicado: (2015)

Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity
por: Senagolage, Madhavi D., et al.
Publicado: (2018)

The transcription factor BCL-6 controls early development of innate-like T cells
por: Gioulbasani, Marianthi, et al.
Publicado: (2020)

A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis
por: Sun, Xiao-Jian, et al.
Publicado: (2013)

Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells
por: Ha, Kyungsoo, et al.
Publicado: (2014)

Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
por: Li, Meng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2sk7olvbs1r7nj63mjbpfcvfav